|Rockwell Medical -- USA Stock|| |
USD 5.66 0.17 3.10%
Co-Founder, LifeSci Advisors, LLC
We currently do not have informatin regarding Michael Rice. This executive tanure with Rockwell Medical is not currenlty determined.
Michael Rice Latest Insider Activity
The company has return on total asset (ROA)
of (22.83) %
which means that it has lost $22.83 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE)
of (60.37) %
meaning that it created substantial loss on money invested by shareholders.
Rockwell Medical, Inc. operates as an integrated biopharmaceutical company targeting end-stage renal and chronic kidney diseases in the United States and internationally. Rockwell Medical, Inc. was founded in 1995 and is based in Wixom, Michigan. Rockwell Medical operates under Drug Manufacturers - Major classification in USA and traded on NASDAQ General Markets. It employs 300 people.Rockwell Medical (RMTI) is traded on NASDAQ General Markets in USA. It is located in MICHIGAN, U.S.A and employs 300 people. Rockwell Medical is listed under Medical Equipment category by Fama And French industry classification.
Rockwell Medical Leadership Team
|John Cooper, Director|
|David Domzalski, Director|
|Thomas Klema, President, MBA|
|Ajay Gupta, Executive|
|Ronald Boyd, Director|
|Lisa Colleran, Director|
|Kenneth Holt, Director|
|Benjamin Wolin, Chairman|
|Raymond Pratt, Executive, Ph.D|
|Robin Smith, Director, MBA|
|Patrick Bagley, Director|
|Robert Chioini, Chairman|
|Michael Rice, Founder|
Stock Performance Indicators
Most of Macroaxis users are at this time bullish on Rockwell Medical. What is your perspective on investing in Rockwell Medical? Are you bullish or bearish?